Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease

Abstract The primary objective of this study was to evaluate how schizophrenia (SCH) spectrum disorders and applied antipsychotic (AP) treatment affect serum level of amino acids (AAs) and biogenic amines (BAs) in the early course of the disorder. We measured 21 different AAs and 10 BAs in a sample...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Madis Parksepp, Liisa Leppik, Kadri Koch, Kärt Uppin, Raul Kangro, Liina Haring, Eero Vasar, Mihkel Zilmer
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/29a5ddd501d349ad867fc08c7190aed6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!